{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:15:48Z","timestamp":1782216948321,"version":"3.54.5"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the feasibility and effectiveness of hysteroscopic myomectomy for treating International Federation of Gynecology and Obstetrics type 3 myomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study evaluated 26 patients with type 3 myoma who underwent hysteroscopic myomectomy in a teaching hospital between January 2022 and May 2025. Data on surgery time, transurethral resection of prostate syndrome, and complete removal rate were collected. The amount of menstruation which was assessed by pictorial blood loss assessment chart (PBAC). The PBAC, duration of menstrual period, and hemoglobin levels were recorded at 3, 6, and 12 months postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The complete myoma removal rate was 96.15%. One patient developed transurethral resection of prostate syndrome, while no cases of postoperative intrauterine adhesion were detected on three-dimensional (3D) transvaginal ultrasound. A significant reduction in menstrual blood loss was observed after the procedure. Notably, three women conceived naturally within 1 year postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hysteroscopic myomectomy is a viable treatment option for International Federation of Gynecology and Obstetrics type 3 myomas and can effectively relieve menorrhagia in highly selected patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2025.1742020","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:38:18Z","timestamp":1767595098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Feasibility and effectiveness of hysteroscopic myomectomy for type 3 myomas"],"prefix":"10.3389","volume":"12","author":[{"given":"Hui","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14730","article-title":"Uterine fibroids: from observational epidemiology to clinical management","volume":"124","author":"Vercellini","year":"2017","journal-title":"BJOG"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","article-title":"Fibroids and infertility: an updated systematic review of the evidence","volume":"91","author":"Pritts","year":"2009","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.fertnstert.2022.11.021","article-title":"Surgical removal of FIGO type 0 and 1 fibroids ameliorates the expression of endometrial proinflammatory transcription factors and receptivity modulators","volume":"119","author":"Dokuzeyl\u00fcl G\u00fcng\u00f6r","year":"2023","journal-title":"Fertil Steril"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.fertnstert.2011.03.079","article-title":"The FIGO classification of causes of abnormal uterine bleeding in the reproductive years","volume":"95","author":"Munro","year":"2011","journal-title":"Fertil Steril"},{"key":"B5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5301\/je.5000253","article-title":"Effect of non-cavity distorting intramural fibroids on assisted reproduction outcomes: a cohort study","volume":"8","author":"Marqueta","year":"2016","journal-title":"J Endometr Pelvic Pain Disord"},{"key":"B6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.fertnstert.2017.06.034","article-title":"Removal of myomas in asymptomatic patients to improve fertility and\/or reduce miscarriage rate: a guideline","volume":"108","author":"Penzias","year":"2017","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejogrb.2016.06.026","article-title":"Hysteroscopic resection of type 3 myoma: a new challenge?","volume":"205","author":"Capmas","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.fertnstert.2018.01.007","article-title":"Effect of type 3 intramural fibroids on in vitro fertilization\u2013intracytoplasmic sperm injection outcomes: a retrospective cohort study","volume":"109","author":"Yan","year":"2018","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ejogrb.2019.12.018","article-title":"The impact of FIGO type 3 fibroids on in-vitro fertilization outcomes: a nested retrospective case-control study","volume":"247","author":"Bai","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ijgo.14838","article-title":"Impact of FIGO type 3 uterine fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis","volume":"163","author":"Favilli","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12154953","article-title":"Feasibility and surgical outcomes of hysteroscopic myomectomy of FIGO type 3 myoma: a systematic review","volume":"12","author":"Etrusco","year":"2023","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04828-3","article-title":"Hysteroscopic resection of type 3 fibroids could improve the pregnancy outcomes in infertile women: a case\u2013control study","volume":"22","author":"Han","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9180","DOI":"10.26355\/eurrev_202212_30669","article-title":"Surgical removal of intramural fibroids improves the TNF-\u03b1 induced inflammatory events in endometrium","volume":"26","author":"Kali Z","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.fertnstert.2021.06.023","article-title":"Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas","volume":"116","author":"Governini","year":"2021","journal-title":"Fertil Steril"},{"key":"B15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejogrb.2021.11.434","article-title":"Hysteroscopic myomectomy: the guidelines of the international society for gynecologic endoscopy (ISGE)","volume":"268","author":"Loddo","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.52054\/FVVO.14.3.038","article-title":"Endometrial preservation during resection of type II and type III submucosal fibroids","volume":"14","author":"Vorona","year":"2022","journal-title":"Facts Views Vis Obgyn"},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/gyn.2024.0048","article-title":"Evaluating the role of the hysteroscopic cold resection system in combination with electric resection system for the surgical removal of type 3 uterine fibroids: a retrospective case study","volume":"41","author":"Bai","year":"2025","journal-title":"J Gynecol Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633180","article-title":"Understanding the impact of uterine fibroids on human endometrium function","volume":"9","author":"Navarro","year":"2021","journal-title":"Front Cell Dev Biol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1742020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:38:19Z","timestamp":1767595099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1742020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":18,"alternative-id":["10.3389\/fsurg.2025.1742020"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2025.1742020","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1742020"}}